LONDON (Reuters) - Two experimental skin cancer drugs from GlaxoSmithKline - each designed to block different pathways used by tumour cells - look set to steal a march on Roche's pioneering melanoma treatment Zelboraf, according to Citigroup. ...
Source: http://health.yahoo.net/news/s/nm/gsk-melanoma-drugs-may-steal-market-from-roche
Chad Ochocinco Glen Rice Dark Shadows iphone
No comments:
Post a Comment
Note: only a member of this blog may post a comment.